Sonoma Pharmaceuticals gets FDA clearance for Microdacyn solution

June 30, 2026 9:01 AM

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) has received a new FDA 510(k) clearance for its Microdacyn Wound Irrigation Solution, expanding its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found